Literature DB >> 2400990

Medical history and primary liver cancer.

C La Vecchia1, E Negri, B D'Avanzo, P Boyle, S Franceschi.   

Abstract

The relationship between selected aspects of medical history and the risk of primary liver cancer was analyzed in a hospital-based case-control study conducted in Northern Italy on 242 patients with histologically or serologically confirmed hepatocellular carcinoma and 1169 controls in hospital for acute, nonneoplastic, or digestive diseases. Significant associations were observed for clinical history of hepatitis [odds ratio (OR), 3.7; 95% confidence interval (CI), 2.3-5.9], cirrhosis (OR, 16.8; 95% CI, 9.8-28.8), and three or more episodes of transfusion in the past (OR, 2.2; 95% CI, 1.4-4.1). Among other diseases considered, there was a significant association with diabetes (OR, 2.5; 95% CI, 1.7-3.8), and a protection by history of drug allergies (OR, 0.5; 95% CI, 0.2-0.9). These associations were not appreciably modified by allowance for major identified potential confounding factors and were observed for diseases occurring less than 5 or 5 or more years before liver cancer diagnosis, although for cirrhosis the risk was higher in the short term occurrences (OR, 50). For hepatitis, the association was more evident at older ages, confirming the long lead time between infection and cancer occurrence, while for diabetes it was stronger (or restricted) to cases aged less than 60, suggesting a possible specific role of type I diabetes. While for hepatitis, cirrhosis, and blood transfusion this study offers further quantitative estimates of risk in a European population, the possible direct association with diabetes and protection by drug allergy were unexpected, lacked plausible biological or previous epidemiological support, and should be simply regarded as working hypotheses for further work.

Entities:  

Mesh:

Year:  1990        PMID: 2400990

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.

Authors:  Alessandro Mantovani; Giovanni Targher
Journal:  Ann Transl Med       Date:  2017-07

2.  Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C.

Authors:  Junichi Tazawa; Manabu Maeda; Mina Nakagawa; Hideo Ohbayashi; Fumihiko Kusano; Michio Yamane; Yoshinori Sakai; Keiko Suzuki
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

Review 3.  Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism.

Authors:  Juliane I Beier; Gavin E Arteel
Journal:  Exp Biol Med (Maywood)       Date:  2012-01

4.  Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study.

Authors:  Jocelyn S Kasper; Yan Liu; Edward Giovannucci
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

5.  Diabetes mellitus and risk of prostate cancer: a meta-analysis.

Authors:  S Bonovas; K Filioussi; A Tsantes
Journal:  Diabetologia       Date:  2004-05-26       Impact factor: 10.122

6.  Medical history and the risk of multiple myeloma.

Authors:  A Gramenzi; I Buttino; B D'Avanzo; E Negri; S Franceschi; C La Vecchia
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

7.  A case-control study of diabetes mellitus and cancer risk.

Authors:  C La Vecchia; E Negri; S Franceschi; B D'Avanzo; P Boyle
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

Review 8.  Potential Role of the Gut/Liver/Lung Axis in Alcohol-Induced Tissue Pathology.

Authors:  Veronica L Massey; Juliane I Beier; Jeffrey D Ritzenthaler; Jesse Roman; Gavin E Arteel
Journal:  Biomolecules       Date:  2015-09-30

Review 9.  Transitional Remodeling of the Hepatic Extracellular Matrix in Alcohol-Induced Liver Injury.

Authors:  Lauren G Poole; Gavin E Arteel
Journal:  Biomed Res Int       Date:  2016-10-24       Impact factor: 3.411

Review 10.  Organ-Organ Crosstalk and Alcoholic Liver Disease.

Authors:  Lauren G Poole; Christine E Dolin; Gavin E Arteel
Journal:  Biomolecules       Date:  2017-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.